APA (7th ed.) Citation

Symington, E., Rangarajan, S., Lester, W., Madan, B., Pierce, G. F., Raheja, P., . . . Laffan, M. (2024). Long‐term safety and efficacy outcomes of valoctocogene roxaparvovec gene transfer up to 6 years post‐treatment. Haemophilia, 30(2), 320. https://doi.org/10.1111/hae.14936

Chicago Style (17th ed.) Citation

Symington, Emily, et al. "Long‐term Safety and Efficacy Outcomes of Valoctocogene Roxaparvovec Gene Transfer Up to 6 years Post‐treatment." Haemophilia 30, no. 2 (2024): 320. https://doi.org/10.1111/hae.14936.

MLA (9th ed.) Citation

Symington, Emily, et al. "Long‐term Safety and Efficacy Outcomes of Valoctocogene Roxaparvovec Gene Transfer Up to 6 years Post‐treatment." Haemophilia, vol. 30, no. 2, 2024, p. 320, https://doi.org/10.1111/hae.14936.